BRENDA - Enzyme Database show
show all sequences of 4.2.1.134

Very-long-chain fatty acids are required for cell plate formation during cytokinesis in Arabidopsis thaliana

Bach, L.; Gissot, L.; Marion, J.; Tellier, F.; Moreau, P.; Satiat-Jeunemaitre, B.; Palauqui, J.C.; Napier, J.A.; Faure, J.D.; J. Cell Sci. 124, 3223-3234 (2011)

Data extracted from this reference:

Inhibitors
Inhibitors
Commentary
Organism
Structure
flufenacet
-
Arabidopsis thaliana
Organism
Organism
Primary Accession No. (UniProt)
Commentary
Textmining
Arabidopsis thaliana
Q8VZB2
-
-
Source Tissue
Source Tissue
Commentary
Organism
Textmining
root
-
Arabidopsis thaliana
-
Substrates and Products (Substrate)
Substrates
Commentary Substrates
Literature (Substrates)
Organism
Products
Commentary (Products)
Literature (Products)
Organism (Products)
Reversibility
3-hydroxyacyl-CoA
-
720091
Arabidopsis thaliana
enoyl-CoA + H2O
-
-
-
?
Inhibitors (protein specific)
Inhibitors
Commentary
Organism
Structure
flufenacet
-
Arabidopsis thaliana
Source Tissue (protein specific)
Source Tissue
Commentary
Organism
Textmining
root
-
Arabidopsis thaliana
-
Substrates and Products (Substrate) (protein specific)
Substrates
Commentary Substrates
Literature (Substrates)
Organism
Products
Commentary (Products)
Literature (Products)
Organism (Products)
Reversibility
3-hydroxyacyl-CoA
-
720091
Arabidopsis thaliana
enoyl-CoA + H2O
-
-
-
?
General Information
General Information
Commentary
Organism
malfunction
mutation in the pas2 gene causes a reduction of very-long-chain fatty acids levels that lead to specific accumulation of cells in late mitosis with delayed, unfinished or abnormal cell plates
Arabidopsis thaliana
General Information (protein specific)
General Information
Commentary
Organism
malfunction
mutation in the pas2 gene causes a reduction of very-long-chain fatty acids levels that lead to specific accumulation of cells in late mitosis with delayed, unfinished or abnormal cell plates
Arabidopsis thaliana
Other publictions for EC 4.2.1.134
No.
1st author
Pub Med
title
organims
journal
volume
pages
year
Activating Compound
Application
Cloned(Commentary)
Crystallization (Commentary)
Engineering
General Stability
Inhibitors
KM Value [mM]
Localization
Metals/Ions
Molecular Weight [Da]
Natural Substrates/ Products (Substrates)
Organic Solvent Stability
Organism
Oxidation Stability
Posttranslational Modification
Purification (Commentary)
Reaction
Renatured (Commentary)
Source Tissue
Specific Activity [micromol/min/mg]
Storage Stability
Substrates and Products (Substrate)
Subunits
Temperature Optimum [C]
Temperature Range [C]
Temperature Stability [C]
Turnover Number [1/s]
pH Optimum
pH Range
pH Stability
Cofactor
Ki Value [mM]
pI Value
IC50 Value
Activating Compound (protein specific)
Application (protein specific)
Cloned(Commentary) (protein specific)
Cofactor (protein specific)
Crystallization (Commentary) (protein specific)
Engineering (protein specific)
General Stability (protein specific)
IC50 Value (protein specific)
Inhibitors (protein specific)
Ki Value [mM] (protein specific)
KM Value [mM] (protein specific)
Localization (protein specific)
Metals/Ions (protein specific)
Molecular Weight [Da] (protein specific)
Natural Substrates/ Products (Substrates) (protein specific)
Organic Solvent Stability (protein specific)
Oxidation Stability (protein specific)
Posttranslational Modification (protein specific)
Purification (Commentary) (protein specific)
Renatured (Commentary) (protein specific)
Source Tissue (protein specific)
Specific Activity [micromol/min/mg] (protein specific)
Storage Stability (protein specific)
Substrates and Products (Substrate) (protein specific)
Subunits (protein specific)
Temperature Optimum [C] (protein specific)
Temperature Range [C] (protein specific)
Temperature Stability [C] (protein specific)
Turnover Number [1/s] (protein specific)
pH Optimum (protein specific)
pH Range (protein specific)
pH Stability (protein specific)
pI Value (protein specific)
Expression
General Information
General Information (protein specific)
Expression (protein specific)
KCat/KM [mM/s]
KCat/KM [mM/s] (protein specific)
748533
Liang
Transcriptomic profiling and ...
Aurantiochytrium sp., Aurantiochytrium sp. PKUSW7
Mar. Drugs
16
310-324
2018
-
1
1
-
1
-
-
-
-
-
-
2
-
4
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
1
1
-
-
1
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
1
2
2
1
-
-
749092
Morineau
Dual fatty acid elongase comp ...
Arabidopsis thaliana, Saccharomyces cerevisiae
PLoS ONE
11
e0160631
2016
-
-
1
-
-
-
-
-
1
-
-
-
-
6
-
-
-
-
-
6
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
8
-
-
-
-
-
-
-
-
-
-
-
-
-
5
8
-
-
-
749134
Ianiri
Phs1 and the synthesis of ver ...
Sporobolomyces sp. (in: Microbotryomycetes), Sporobolomyces sp. (in: Microbotryomycetes) IAM13481
PLoS ONE
9
e105147
2014
-
-
1
-
1
-
-
-
-
-
-
-
-
8
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
2
2
-
-
-
720091
Bach
Very-long-chain fatty acids ar ...
Arabidopsis thaliana
J. Cell Sci.
124
3223-3234
2011
-
-
-
-
-
-
1
-
-
-
-
-
-
3
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
1
-
-
1
-
-
-
-
-
-
-
-
-
-
1
1
-
-
-
719491
Ikeda
Characterization of four mamma ...
Homo sapiens
FEBS Lett.
582
2435-2440
2008
-
-
1
-
-
-
-
4
1
-
4
-
-
4
-
-
-
-
-
1
-
-
1
1
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
4
1
-
4
-
-
-
-
-
-
1
-
-
1
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
719847
Kihara
Membrane topology and essentia ...
Saccharomyces cerevisiae
J. Biol. Chem.
283
11199-11209
2008
-
-
-
-
21
-
-
-
1
-
-
1
-
3
-
1
-
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
21
-
-
-
-
-
1
-
-
1
-
-
1
-
-
-
-
-
2
-
-
-
-
-
-
-
-
-
-
2
2
-
-
-
720893
Bach
The very-long-chain hydroxy fa ...
Arabidopsis thaliana
Proc. Natl. Acad. Sci. USA
105
14727-14731
2008
-
-
1
-
-
-
-
-
1
-
-
-
-
4
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
-
1
-
-
-
-
-
-
-
-
-
-
2
2
-
-
-